<DOC>
	<DOCNO>NCT01677611</DOCNO>
	<brief_summary>Animal study indicate resveratrol , phytoalexin enrich skin red grape constituent red wine , associate longevity likely increase production protein , SIRT1 . The trial proof-of-concept study primarily design examine first time human , effect 12 week oral resveratrol skeletal muscle SIRT1 expression 10 patient T2DM randomize , placebo-controlled , double-blind fashion . Secondary outcome include measure AMPK , p-AMPK GLUT4 expression level , energy expenditure , physical activity level , distribution abdominal adipose tissue skeletal muscle fiber type composition , body weight , HbA1c , plasma lipid subfraction , adiponectin level insulin sensitivity .</brief_summary>
	<brief_title>Effects Resveratrol Patients With Type 2 Diabetes</brief_title>
	<detailed_description>Eligible criterion include Chinese male , age 40 69 year old , T2DM HbA1c 7.1 12 % stable oral hypoglycemic regimen past 3 month . Subjects insulin-dependent , renal liver impairment terminally ill exclude .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>1 . Ability give inform consent 2 . Chinese Male 3 . Age 40 69 yr old 4 . For subject type 2 diabetes mellitus Diagnosis type 2 diabetes mellitus base MOH criterion , HbA1c &gt; 6.5 screen Willing abstain ingest large quantity resveratrolcontaining food ( eg . red wine , nut ) Cancer diagnosis currently treatment , clinically detectable , treat within past 5 year Terminal disease palliative care Current excessive alcohol intake ( &gt; 21 unit per week men ; 14 unit per week woman ) On maximal dos 3 &gt; oral hypoglycaemic agent On insulin therapy know type 1 diabetes mellitus Past history document suspected hypoglycemia within last 3 month Past history recurrent hypoglycemia Past history serious hypoglycemia define documented hypoglycemia require hospital admission Past history hyperglycemic emergency within last 6 month Past current history hemorrhagic stroke On antiplatelet agent , nonsteroidal antiinflammatory drug ( NSAIDs ) , anticoagulation therapy omega3 fatty acid History unexplained bleed disorder History grape allergy History allergy local anaesthetic History surgery surgery clip , staple stent Presence cardiac pacemaker metallic foreign body part body On alternative traditional medication Treated another investigational drug within last 6 month Poorly control hypertension ( SBP &gt; /= 160 DBP &gt; /= 100 ) within last one month ALT and/or AST &gt; 1.5 time upper limit normal within last 6 month GFR &lt; 50 ml/min/1.73m2 ( MDRD equation ) within last 6 month</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Resveratrol</keyword>
	<keyword>SIRT1</keyword>
	<keyword>AMPK</keyword>
</DOC>